Prostate cancer decisions — 2022

The Board has granted service connection for prostate cancer, finding that the Veteran's in-service asbestos exposure is at least as likely as not related to his current condition.

The Veteran's claim for a higher disability rating for other specified trauma and stressor related disorder was denied. The effective date of TDIU was granted from December 16, 2013, based on the service-connected disabilities. Basic eligibility for Dependents' Educational Assistance (DEA) was also granted from December 16, 2013.

The Board has remanded the Veteran's claims for service connection for asthma, hypertension, and prostate cancer due to alleged exposure to herbicide agents during service. The claims are being remanded for further development including verification of exposure and a VA examination.

The Veteran's prostate cancer is found to be related to his exposure to toxic substances in service, specifically ionizing radiation and organophosphate agents and pesticides. Service connection for prostate cancer is granted.

The Board has granted the Veteran's claims for service connection for Parkinson's disease and prostate cancer, finding that his exposure to herbicide agents during service in Thailand is presumed. The conditions are considered presumptive due to their association with herbicide agent exposure.

The Veteran's TDIU and DEA benefits are granted with an effective date of November 1, 2019. The Board found the Veteran was unable to engage in substantially gainful employment due to his service-connected disabilities as of this date.

The Board has remanded the cases due to a pre-decisional duty to assist error regarding obtaining outstanding medical records.

The Board has remanded the claims for hypertension, GERD, and residuals of prostate cancer due to a lack of formal findings regarding the Veteran's exposure to herbicide agents or napalm. The claims are being returned for further development.

The Veteran's appeal is dismissed due to his death. The Board has no jurisdiction to adjudicate the merits of this case.

The Board denied service connection for coronary artery disease and prostate cancer, finding that the conditions were not incurred during active military service.

The Board has granted service connection for the Veteran's prostate cancer, impotency as secondary to prostate cancer, and incontinence as secondary to prostate cancer. The Board found that his prostate cancer is related to his exposure to contaminated water at Camp Lejeune during service.

The Board found that the reduction of the Veteran's prostate cancer disability rating from 100% to 20% was proper and denied a higher rating for prostate cancer.

The Board denied service connection for the cause of the Veteran's death, finding that there is no medical evidence supporting a nexus between his childhood diptheria and heart failure.

The Veteran's claims for higher ratings for coronary artery disease, colon cancer residuals, and prostate cancer residuals are being remanded due to a duty to assist error. The VA needs to obtain the Veteran's private treatment records from Dr. M.T. and clarify whether his prostate cancer was active and if he was receiving any current treatment.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there is not a relationship between his in-service prostatitis and his current prostate cancer. The Board also denied the TDIU claim.,The evidence did not support a nexus between the Veteran's service-connected prostatitis and his diagnosed prostate cancer.

The Board has granted a 40 percent rating for prostate cancer with voiding dysfunction, effective December 1, 2020. The decision is based on the Veteran's reported symptoms and the VA examination findings.

The Veteran's service-connected ischemic heart disease and prostate cancer rendered him unable to secure or follow substantially gainful employment as of July 3, 2019. An effective date of July 3, 2019 is granted for the award of total disability rating based on individual unemployability (TDIU).

The Veteran's prostate cancer residuals disability is granted a rating of 40 percent, but not greater. The ED disability remains noncompensable.

The Veteran's prostate cancer residuals disability is granted a rating of 40 percent, but not greater. The ED disability remains noncompensable.

The Veteran's service-connected disabilities render him unable to secure or follow a substantially gainful occupation, and the Board finds that his TDIU claim is granted.